Literature DB >> 23370958

Pseudohypoaldosteronism without nephropathy masking salt-wasting congenital adrenal hyperplasia genetically confirmed.

Carla Balcells1, Teresa Gili, Jacobo Pérez, Raquel Corripio.   

Abstract

Salt-losing crisis with hypoglycaemia and shock are the main manifestations of congenital adrenal hyperplasia (CAH) during the first weeks of life, while hyponatremia and hyperpotassemia alone are seen on mineralocorticoid deficiency or resistance. During the neonatal period, high blood levels of adrenal steroids may lead to confusing laboratory tests not being able to identify the real level of each hormone. A 33-day-old male baby was admitted at the emergency department with severe salt-losing crisis (Na(+) 99 mEq/l and K(+) 9.4 mEq/l) and mild acidosis. No hypoglycaemia or hypotension was seen. Urinary tract infection was excluded. Despite treatment with hydrocortisone and fludrocortisone, hyperpotassemia was hard to control. Laboratory tests could not differentiate between pseudohypoaldosteronism and CAH as both the aldosterone (2454 pg/ml) and 17-OH-progesterone (656.6 ng/ml) levels were high. Diagnosis was made, thanks to the genetic study that proved classical mutations in both alleles of the 21-hydroxylase gene.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23370958      PMCID: PMC3603811          DOI: 10.1136/bcr-2012-008281

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  [Usefulness of molecular analysis in the differential diagnosis of congenital 21-hidroxylase deficiency detected in neonatal screening].

Authors:  Leandro Soriano Guillén; María Velázquez De Cuellar Paracchi; Begoña Ezquieta
Journal:  Med Clin (Barc)       Date:  2009-09-18       Impact factor: 1.725

2.  Near-fatal misdiagnosis of congenital adrenal hyperplasia.

Authors:  G R Frank; D Y Yoon; P M Kreitzer
Journal:  J Pediatr       Date:  1997-07       Impact factor: 4.406

3.  Ultrasound findings in the adreno-genital syndrome (congenital adrenal hyperplasia).

Authors:  P J Bryan; A A Caldamone; S C Morrison; B S Yulish; R Owens
Journal:  J Ultrasound Med       Date:  1988-12       Impact factor: 2.153

4.  Clinical utility of adrenal ultrasonography in the diagnosis of congenital adrenal hyperplasia.

Authors:  I Al-Alwan; O Navarro; D Daneman; A Daneman
Journal:  J Pediatr       Date:  1999-07       Impact factor: 4.406

5.  Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany.

Authors:  N Krone; A Braun; A A Roscher; D Knorr; H P Schwarz
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

6.  Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline.

Authors:  Phyllis W Speiser; Ricardo Azziz; Laurence S Baskin; Lucia Ghizzoni; Terry W Hensle; Deborah P Merke; Heino F L Meyer-Bahlburg; Walter L Miller; Victor M Montori; Sharon E Oberfield; Martin Ritzen; Perrin C White
Journal:  J Clin Endocrinol Metab       Date:  2010-09       Impact factor: 5.958

Review 7.  Recent advances in diagnosis, treatment, and outcome of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Felix G Riepe; Wolfgang G Sippell
Journal:  Rev Endocr Metab Disord       Date:  2007-12       Impact factor: 6.514

  7 in total
  3 in total

Review 1.  Molecular Diagnosis of Steroid 21-Hydroxylase Deficiency: A Practical Approach.

Authors:  María Arriba; Begoña Ezquieta
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-29       Impact factor: 5.555

2.  False elevation of serum cortisol in chemiluminescence immunoassay by Siemens Advia Centaur XP system in 21-hydroxylase deficiency: an 'endocrine laboma'.

Authors:  Neeti Agrawal; Partha Pratim Chakraborty; Anirban Sinha; Animesh Maiti
Journal:  BMJ Case Rep       Date:  2020-09-07

3.  Pseudohypoaldosteronism in a neonate presenting as life-threatening arrhythmia.

Authors:  Sudeep K Rajpoot; Carlos Maggi; Amrit Bhangoo
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2014-03-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.